Therapeutic Asset Ratings
178 results matching 1 filter
133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Cetuximab
Fruquintinib
Zhejiang University
P2
CCC
(53)
Cetuximab
Fulzerasib
Zhejiang University
P2
CCC
(53)
Cetuximab
KRAS G12C Mutant Advanced Solid Tumors
Zhejiang University
P2
CCC
(53)
Cetuximab
RAS
Zhejiang University
P2
CCC
(53)
Dfn-15
MSI-L
Zhejiang University
P2
CCC
(53)
Dfn-15
pMMR
Zhejiang University
P2
CCC
(53)
Eloxatin
MSI-L
Zhejiang University
P2
CCC
(53)
Ethiodized Oil
Adjuvant Therapy
Zhejiang University
P2
CCC
(53)
Fruquintinib
BRAF
Zhejiang University
P2
CCC
(53)
Fruquintinib
Cetuximabβ
Zhejiang University
P2
CCC
(53)
Fruquintinib
Fruquintinib
Zhejiang University
P2
CCC
(53)
Fruquintinib
RAS
Zhejiang University
P2
CCC
(53)
Fulzerasib
Cetuximab N01
Zhejiang University
P2
CCC
(53)
Fulzerasib
Fulzerasib
Zhejiang University
P2
CCC
(53)
Fulzerasib
KRAS G12C Mutant Advanced Solid Tumors
Zhejiang University
P2
CCC
(53)
Hrs-4642
Borderline Resectable Pancreatic Adenocarcinoma
Zhejiang University
P2
CCC
(53)
Hrs-4642
Metastatic Pancreatic Carcinoma
Zhejiang University
P2
CCC
(53)
ibi343
Advanced Pancreatic Cancers
Zhejiang University
P2
CCC
(53)
ibi343
Borderline Resectable Pancreatic Adenocarcinoma
Zhejiang University
P2
CCC
(53)
IMMUNOGLOBULIN G1, ANTI-(HUMANIZED MOUSE MONOCLONAL HR3 .BETA.1 CHAIN ANTI-HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR), DISULFIDE WITH HUMANIZED MOUSE MONOCLONAL HR3 .KAPPA.-CHAIN, DIMER
Borderline Resectable Pancreatic Adenocarcinoma
Zhejiang University
P2
CCC
(53)
IMMUNOGLOBULIN G1, ANTI-(HUMANIZED MOUSE MONOCLONAL HR3 .BETA.1 CHAIN ANTI-HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR), DISULFIDE WITH HUMANIZED MOUSE MONOCLONAL HR3 .KAPPA.-CHAIN, DIMER
Metastatic Pancreatic Carcinoma
Zhejiang University
P2
CCC
(53)
Pyrotinib
Adjuvant Therapy
Zhejiang University
P2
CCC
(53)
rc48-adc
Adjuvant Therapy
Zhejiang University
P2
CCC
(53)
Rivoceranib
Metastatic Pancreatic Carcinoma
Zhejiang University
P2
CCC
(53)
Serplulimab
MSI-L
Zhejiang University
P2
CCC
(53)
Showing 26 to 50 of 178 assets
Previous
Page 2 of 8
Next